Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Mondino

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administrationAnna Casati, Valérie S Zimmermann, Fabio Benigni, et al.
Cancer Research|March 30, 2013
Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settingsAlessia Ricupito, Matteo Grioni, Arianna Calcinotto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2012
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapyArianna Calcinotto, Matteo Grioni, Elena Jachetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccinationValérie S Zimmermann, Anna Casati, Chris Schiering, et al.
Journal of Cell Science|August 27, 2011
A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cellsRomana Tomasoni, Sara Negrini, Stefania Fiordaliso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell TherapyAngela Rita Elia, Matteo Grioni, Veronica Basso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Concurrent allorecognition has a limited impact on posttransplant vaccinationTeresa Manzo, Rodrigo Hess Michelini, Veronica Basso, et al.
The Journal of Cell Biology|January 28, 2004
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferationRoberta Palumbo, Maurilio Sampaolesi, Francesco De Marchis, et al.
Molecular and Cellular Biology|November 30, 2005
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursorsDmitri Penkov, Patrizia Di Rosa, Luis Fernandez Diaz, et al.
Experimental Eye Research|June 1, 2022
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical modelFilippo Bonelli, Romina Mayra Lasagni Vitar, Francesco Giorgio Merlo Pich, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administrationAnna Casati, Valérie S Zimmermann, Fabio Benigni, et al.
Cancer Research|March 30, 2013
Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settingsAlessia Ricupito, Matteo Grioni, Arianna Calcinotto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2012
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapyArianna Calcinotto, Matteo Grioni, Elena Jachetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccinationValérie S Zimmermann, Anna Casati, Chris Schiering, et al.
Journal of Cell Science|August 27, 2011
A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cellsRomana Tomasoni, Sara Negrini, Stefania Fiordaliso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell TherapyAngela Rita Elia, Matteo Grioni, Veronica Basso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Concurrent allorecognition has a limited impact on posttransplant vaccinationTeresa Manzo, Rodrigo Hess Michelini, Veronica Basso, et al.
The Journal of Cell Biology|January 28, 2004
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferationRoberta Palumbo, Maurilio Sampaolesi, Francesco De Marchis, et al.
Molecular and Cellular Biology|November 30, 2005
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursorsDmitri Penkov, Patrizia Di Rosa, Luis Fernandez Diaz, et al.
Experimental Eye Research|June 1, 2022
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical modelFilippo Bonelli, Romina Mayra Lasagni Vitar, Francesco Giorgio Merlo Pich, et al.
Pageof 9